Pancreatic cancer drug Daraxonrasib gets approval from FDA: All you need to know
Comments Off on Pancreatic cancer drug Daraxonrasib gets approval from FDA: All you need to know
August 27, 2026
WASHINGTON (AP) — The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of cancer. FDA officials gave expedited…